AAAAAA
Results:
1-20
|
Results: 20
Authors:
FOSS FM
RAUBITSCHECK A
MULSHINE JL
FLEISHER TA
REYNOLDS JC
PAIK CH
NEUMANN RD
BOLAND C
PERENTESIS P
BROWN MR
FRINCKE JM
LOLLO CP
LARSON SM
CARRASQUILLO JA
Citation: Fm. Foss et al., PHASE-I STUDY OF THE PHARMACOKINETICS OF A RADIOIMMUNOCONJUGATE, Y-90T101, IN PATIENTS WITH CD5-EXPRESSING LEUKEMIA AND LYMPHOMA, Clinical cancer research, 4(11), 1998, pp. 2691-2700
Authors:
SWEENEY EB
FOSS FM
MURPHY JR
VANDERSPEK JC
Citation: Eb. Sweeney et al., INTERLEUKIN-7 (IL-7) RECEPTOR-SPECIFIC CELL-KILLING BY DAB(389) IL-7 - A NOVEL AGENT FOR THE ELIMINATION OF IL-7 RECEPTOR-POSITIVE CELLS, Bioconjugate chemistry, 9(2), 1998, pp. 201-207
Authors:
ABDELBAKI J
STEFANATO CM
KOH HK
DEMIERRE MF
FOSS FM
Citation: J. Abdelbaki et al., EARLY DETECTION OF CUTANEOUS LYMPHOMA, Oncology, 12(10), 1998, pp. 1521-1530
Authors:
URBANO A
KOC Y
FOSS FM
Citation: A. Urbano et al., ARGININE BUTYRATE DOWN-REGULATES P(210) BCR-ABL EXPRESSION AND INDUCES APOPTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS, Leukemia, 12(6), 1998, pp. 930-936
Authors:
POWSNER RA
ZIETMAN AL
FOSS FM
Citation: Ra. Powsner et al., BONE-MARROW SUPPRESSION AFTER SR-89 THERAPY AND LOCAL RADIATION-THERAPY IN PATIENTS WITH DIFFUSE MARROW INVOLVEMENT, Clinical nuclear medicine, 22(3), 1997, pp. 147-150
Authors:
DEMIERRE MF
FOSS FM
KOH HK
Citation: Mf. Demierre et al., PROCEEDINGS OF THE S-T-CELL-LYMPHOMA-(CTCL)-TREATMENT-RECOMMENDATIONS, Journal of the American Academy of Dermatology, 36(3), 1997, pp. 460-466
Authors:
BUNN PA
FOSS FM
Citation: Pa. Bunn et Fm. Foss, T-CELL LYMPHOMA CELL-LINES (HUT102 AND HUT78) ESTABLISHED AT THE NATIONAL-CANCER-INSTITUTE - HISTORY AND IMPORTANCE TO UNDERSTANDING THE BIOLOGY, CLINICAL-FEATURES, AND THERAPY OF CUTANEOUS T-CELL LYMPHOMAS (CTCL) AND ADULT T-CELL LEUKEMIA-LYMPHOMAS (ATLL), Journal of cellular biochemistry, 1996, pp. 12-23
Authors:
KOH HK
FOSS FM
Citation: Hk. Koh et Fm. Foss, CUTANEOUS T-CELL LYMPHOMA - PREFACE, Hematology/oncology clinics of North America, 9(5), 1995, pp. 11-11
Authors:
FOSS FM
SAUSVILLE EA
Citation: Fm. Foss et Ea. Sausville, PROGNOSIS AND STAGING OF CUTANEOUS T-CELL LYMPHOMA, Hematology/oncology clinics of North America, 9(5), 1995, pp. 1011
Authors:
ROSEN ST
FOSS FM
Citation: St. Rosen et Fm. Foss, CHEMOTHERAPY FOR MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME, Hematology/oncology clinics of North America, 9(5), 1995, pp. 1109
Authors:
FOSS FM
KUZEL TM
Citation: Fm. Foss et Tm. Kuzel, EXPERIMENTAL THERAPIES IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA, Hematology/oncology clinics of North America, 9(5), 1995, pp. 1127
Authors:
COHEN R
JAFFE ES
STETLERSTEVENSON MA
SAUSVILLE EA
DENIGRIS EC
WOODWORTH T
FOSS FM
Citation: R. Cohen et al., BILATERAL ADRENAL HEMORRHAGE AND ADRENAL INSUFFICIENCY IN A PATIENT WITH LYMPHOMATOUS ADRENAL INFILTRATION FOLLOWING ADMINISTRATION OF A FUSION TOXIN (DAB(486)INTERLEUKIN-2), Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 229-233
Authors:
FOSS FM
KOC Y
STETLERSTEVENSON MA
NGUYEN DT
OBRIEN MC
TURNER R
SAUSVILLE EA
Citation: Fm. Foss et al., COSTIMULATION OF CUTANEOUS T-CELL LYMPHOMA-CELLS BY INTERLEUKIN-7 ANDINTERLEUKIN-2 - POTENTIAL AUTOCRINE OR PARACRINE EFFECTORS IN THE SEZARY-SYNDROME, Journal of clinical oncology, 12(2), 1994, pp. 326-335
Authors:
FOSS FM
IHDE DC
LINNOILA IR
FISCHMANN AB
SCHECHTER GP
COTELINGAM JD
STEINBERG SM
GHOSH BC
STOCKER JL
BASTIAN A
PHARES JC
SAUSVILLE EA
Citation: Fm. Foss et al., PHASE-II TRIAL OF FLUDARABINE PHOSPHATE AND INTERFERON ALFA-2A IN ADVANCED MYCOSIS-FUNGOIDES SEZARY-SYNDROME, Journal of clinical oncology, 12(10), 1994, pp. 2051-2059
Authors:
CHESON BD
VENA DA
FOSS FM
SORENSEN JM
Citation: Bd. Cheson et al., NEUROTOXICITY OF PURINE ANALOGS - A REVIEW, Journal of clinical oncology, 12(10), 1994, pp. 2216-2228
Authors:
FUKUSHIMA P
MCCLANAHAN J
GREINER T
JAFFE ES
SAUSVILLE EA
FOSS FM
KUCHNIO M
STETLERSTEVENSON M
Citation: P. Fukushima et al., FLOW CYTOMETRIC DETECTION OF NEOPLASTIC T-CELLS IN PATIENTS WITH MYCOSIS-FUNGOIDES (MF) BASE UPON LEVELS OF T-CELL RECEPTOR EXPRESSION, Laboratory investigation, 70(1), 1994, pp. 10000108-10000108
Authors:
FOSS FM
BORKOWSKI TA
GILLIOM M
STETLERSTEVENSON M
JAFFE ES
FIGG WD
TOMPKINS A
BASTIAN A
NYLEN P
WOODWORTH T
UDEY MC
SAUSVILLE EA
Citation: Fm. Foss et al., CHIMERIC FUSION PROTEIN TOXIN DAB(486) IL-2 IN ADVANCED MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME - CORRELATION OF ACTIVITY AND INTERLEUKIN-2 RECEPTOR EXPRESSION IN A PHASE-II STUDY, Blood, 84(6), 1994, pp. 1765-1774
Authors:
KUCHNIO M
SAUSVILLE EA
JAFFE ES
GREINER T
FOSS FM
MCCLANAHAN J
FUKUSHIMA P
STETLERSTEVENSON MA
Citation: M. Kuchnio et al., FLOW CYTOMETRIC DETECTION OF NEOPLASTIC T-CELLS IN PATIENTS WITH MYCOSIS-FUNGOIDES BASED ON LEVELS OF T-CELL RECEPTOR EXPRESSION, American journal of clinical pathology, 102(6), 1994, pp. 856-860
Authors:
GRAHAM SJ
SHARPE RW
STEINBERG SM
COTELINGAM JD
SAUSVILLE EA
FOSS FM
Citation: Sj. Graham et al., PROGNOSTIC IMPLICATIONS OF A BONE-MARROW HISTOPATHOLOGIC CLASSIFICATION-SYSTEM IN MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME, Cancer, 72(3), 1993, pp. 726-734
Authors:
FOSS FM
KOC Y
SANDERS D
OBRIEN M
FALLER D
MCCAFFREY R
Citation: Fm. Foss et al., BIOMODULATORY EFFECTS OF BUTYRIC-ACID DERIVATIVES ON LEUKEMIA AND LYMPHOMA-CELLS, Blood, 82(10), 1993, pp. 10000564-10000564
Risultati:
1-20
|